Primary Care

 

Two Southeast Asian groups up for sale and an Indian group to IPO

In contrast to Europe, South and Southeast Asia are continuing to see significant deal activity. HBI hears that SAFE Fertility Group, one of Thailand’s largest IVF providers, and Qualitas Medical Group, a primary care chain with practices across Malaysia, Singapore and Australia, are up for sale. On top of this, Agilus Diagnostics, one of India’s largest labs groups, is set to IPO.
August 10, 2023

UK Government turns to for-profits to bust backlog

The UK independent sector is gearing up for an explosion in backlog-busting public outsourcing. The for-profit hospital, ophthalmology and imaging markets in particular look set for a significant boost according to wide-reaching government plans announced today (January 4). 
August 4, 2023

HBI 2023 Panel: This time it’s personal: rethinking patient pathways

When we talk about personalised medicine, we often hear about the therapy component, but less so about the service element of care. In an HBI 2023 panel entitled ‘This time it's personal: rethinking patient pathways’ speakers argued that's exactly where personalisation should be occurring.
July 18, 2023

75 years on: is the future of the NHS private?

The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.
July 14, 2023

HBI 2023: The evolution in primary care

There is a unique opportunity in the primary care sector to build a more efficient, effective and prevention-oriented health care system. Panellists at HBI 2023’s ‘The evolution in primary care panel’, explained that many of the tools needed to do so already exist.
July 11, 2023

HBI 2023: Healthcare regulation – opportunities and risks

Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.
July 7, 2023

Laboratory diagnostics – where after Covid?

Diagnostic labs saw massive growth during Covid. How has this changed the long-term outlook for the sector? For instance, has Covid enabled the sector to successfully build new relationships with government and public payors? This session also explores growth opportunities in outsourcing, new tech, verticalisation and emerging markets Speakers include: Jerome Thill, CEO, Groupe  Cerba […]
June 21, 2023

Opportunities in diagnostic imaging and teleradiology

Diagnostic imaging has seen a huge M&A boom as investors seek to consolidate Western Europe. What’s driving domestic and cross-border consolidation? What are the benefits of scale? Operators of diagnostic clinics have also been acquiring specialist teleradiology groups (Mednax/vRad, Unilabs/TMC, I-MED/Vital, Evidia/4ways). What’s the winning model in teleradiology – independent or vertically integrated? Where are […]
June 21, 2023
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us